Li J, Shen J, Wang Z, Xu H, Wang Q, Chai S, Fu P, Huang T, Anas O, Zhao H, Li J, Xiong N (2019) ELTD1 facilitates glioma proliferation, migration and invasion by activating JAK/STAT3/HIF-1α signaling axis. Sci Rep 9:13904
Article
PubMed
PubMed Central
Google Scholar
Balamurugan K (2016) HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer 138(5):1058–1066
Article
CAS
PubMed
Google Scholar
Liu ZZ, Tian YF, Wu H, Ouyang SY, Kuang WL (2020) LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis. Neoplasma 67(1):111–118
Article
CAS
PubMed
Google Scholar
Liu Q, Cao P (2015) Clinical and prognostic significance of HIF-1α in glioma patients: a meta-analysis. Int J Clin Exp Med 8(12):22073
CAS
PubMed
PubMed Central
Google Scholar
Renfrow JJ, Soike MH, Debinski W, Ramkissoon SH, Mott RT, Frenkel MB, Sarkaria JN, Lesser GJ, Strowd RE (2018) Hypoxia-inducible factor 2α: a novel target in gliomas. Future Med Chem 10(18):2227–2236
Article
CAS
PubMed
PubMed Central
Google Scholar
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251
Article
CAS
PubMed
PubMed Central
Google Scholar
Clara CA, Marie SK, de Almeida JR, Wakamatsu A, Oba-Shinjo SM, Uno M, Neville M, Rosemberg S (2014) Angiogenesis and expression of PDGF-C, VEGF, CD 105 and HIF-1α in human glioblastoma. Neuropathology 34(4):343–352
CAS
PubMed
Google Scholar
Dallabona M, Sarubbo S, Merler S, Corsini F, Pulcrano G, Rozzanigo U, Barbareschi M, Chioffi F (2017) Impact of mass effect, tumor location, age, and surgery on the cognitive outcome of patients with high-grade gliomas: a longitudinal study. Neuro-Oncol Pract 4(4):229–240
Article
Google Scholar
Roux A, Roca P, Edjlali M, Sato K, Zanello M, Dezamis E, Gori P, Lion S, Fleury A, Dhermain F, Meder JF (2019) MRI atlas of IDH wild-type supratentorial glioblastoma: probabilistic maps of phenotype, management, and outcomes. Radiology 293(3):633–643
Article
PubMed
Google Scholar
Rodríguez-Florido MA, Feria-Romero IA, Nettel-Rueda B, Guerrero-Cantera J, Orozco-Suárez S, Chavez JA, Guinto G, Grijalva I (2019) Semi-quantitative evaluation of brain gliomas in adults: a focus on neuropathological characteristics. Gac Med Mex 155(5):439–446
PubMed
Google Scholar
Huang J, Yu J, Tu L, Huang N, Li H, Luo Y (2019) Isocitrate dehydrogenase mutations in glioma: from basic discovery to therapeutics development. Front Oncol 9:506
Article
PubMed
PubMed Central
Google Scholar
Fukuya Y, Ikuta S, Maruyama T, Nitta M, Saito T, Tsuzuki S, Chernov M, Kawamata T, Muragaki Y (2019) Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas. J Neurooncol 144(3):519–528
Article
CAS
PubMed
Google Scholar
Rathore S, Niazi T, Iftikhar MA, Chaddad A (2020) Glioma grading via analysis of digital pathology images using machine learning. Cancers 12(3):578
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu WM, Wang F, Xi SY, Zhang X, Lai JP, Wu HY, Liu LL, Sai K, Zeng J (2020) Practice of the new integrated molecular diagnostics in gliomas: experiences and new findings in a single Chinese center. J Cancer 11(6):1371
Article
CAS
PubMed
PubMed Central
Google Scholar
Robinson C, Kleinschmidt-DeMasters BK (2017) IDH1-mutation in diffuse gliomas in persons age 55 years and over. J Neuropathol Exp Neurol 76(2):151–154
PubMed
Google Scholar
Barresi V, Eccher A, Simbolo M, Cappellini R, Ricciardi GK, Calabria F, Cancedda M, Mazzarotto R, Bonetti B, Pinna G, Sala F (2020) Diffuse gliomas in patients aged 55 years or over: a suggestion for IDH mutation testing. Neuropathology 40(1):68–74
Article
CAS
PubMed
Google Scholar
Di Carlo DT, Duffau H, Cagnazzo F, Benedetto N, Morganti R, Perrini P (2020) IDH wild-type WHO grade II diffuse low-grade gliomas. A heterogeneous family with different outcomes. Systematic review and meta-analysis. Neurosur Rev 43(2):383–395
Article
Google Scholar
Deng L, Xiong P, Luo Y, Bu X, Qian S, Zhong W, Lv S (2018) Association between IDH1/2 mutations and brain glioma grade. Oncol Lett 16(4):5405–5409
PubMed
PubMed Central
Google Scholar
Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ (2019) Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis. Eur Radiol 29(2):745–758
Article
PubMed
Google Scholar
Potharaju M, Mathavan A, Mangaleswaran B, Patil S, John R, Ghosh S, Kalavakonda C, Ghosh M, Verma RS (2019) Clinicopathological analysis of HIF-1alpha and TERT on survival outcome in glioblastoma patients: a prospective, single institution study. J Cancer 10(11):2397
Article
CAS
PubMed
PubMed Central
Google Scholar
Hao C, Chen G, Zhao H, Li Y, Chen J, Zhang H, Li S, Zhao Y, Chen F, Li W, Jiang WG (2020) PD-L1 expression in glioblastoma, the clinical and prognostic significance: a systematic literature review and meta-analysis. Front Oncol 10:1015
Article
PubMed
PubMed Central
Google Scholar
Gately L, Mclachlan SA, Philip J et al (2019) Molecular profile of long-term survivors of glioblastoma. A scoping review of the literature. J Clin Neurosci 68:1–8
Article
CAS
PubMed
Google Scholar
Sfifou F, Hakkou EM, Bouaiti EA, Slaoui M, Errihani H, Al Bouzidi A, Abouqal R, El Ouahabi A, Cherradi N (2021) Correlation of immunohistochemical expression of HIF-1alpha and IDH1 with clinicopathological and therapeutic data of moroccan glioblastoma and survival analysis. Ann Med Surg 69:102731
Article
Google Scholar
Sfifou F, Ouzir M, Hakkou EM, Obtel M, Errihani H, Al Bouzidi A, Abouqal R, El Ouahabi A, Cherradi N (2022) Immunohistochemical expression of HIF-1α, IDH1 and TP53: prognostic profile of Moroccan patients with diffuse glioma. J Chem Neuroanat 119:102056
Article
CAS
PubMed
Google Scholar
Medina Villaamil V, Alvarez Garcia A, AparicioGallego G, Díaz Prado S, Rivas Lopez LA, SantamarinaCainzos I, ValladaresAyerbes M, AntónAparicio LM (2011) Tissue array analysis for the differentiation of gliosis from gliomas. Mol Med Rep 4(3):451–457
CAS
PubMed
Google Scholar
Ibrahim S, Saleh IH (2016) The expression of Hypoxia-inducible factor-1 in astrocytoma
Chen W, Cheng X, Wang X, Wang J, Wen X, Xie C, Liao C (2019) Clinical implications of hypoxia-inducible factor-1α and caveolin-1 overexpression in isocitrate dehydrogenase-wild type glioblastoma multiforme. Oncol Lett 17(3):2867–2873
CAS
PubMed
PubMed Central
Google Scholar
Liu S, Liu X, Zhang C, Shan W, Qiu X (2021) T-cell exhaustion status under high and low levels of hypoxia-inducible factor 1α expression in glioma. Front Pharmacol 12:1744
Google Scholar
Ding XC, Wang LL, Zhang XD, Xu JL, Li PF, Liang H, Zhang XB, Xie L, Zhou ZH, Yang J, Weichselbaum RR (2021) The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia. J Hematol Oncol 14(1):1–5
Article
Google Scholar
Domènech M, Hernández A, Plaja A, Martínez-Balibrea E, Balañà C (2021) Hypoxia: the cornerstone of glioblastoma. Int J Mol Sci 22(22):12608
Article
PubMed
PubMed Central
Google Scholar
Li H, Wang S, Wang Y (2021) IDH1-R132H mutation inhibits the proliferation and glycolysis of glioma cells by regulating the HIF-1α/LDHA pathway
Zhao S, Lin Y, Xu W et al (2009) (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324:261–265
Article
CAS
PubMed
PubMed Central
Google Scholar
Meng FW, Liu FS, Liu WH, Li L, Jie LL (2020) Formation of new lymphatic vessels in glioma: an immunohistochemical analysis. Neuropathology 40(3):215–223
Article
CAS
PubMed
PubMed Central
Google Scholar